William Burgan

2.4k total citations
27 papers, 1.9k citations indexed

About

William Burgan is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, William Burgan has authored 27 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Genetics. Recurrent topics in William Burgan's work include DNA Repair Mechanisms (10 papers), Glioma Diagnosis and Treatment (5 papers) and Epigenetics and DNA Methylation (5 papers). William Burgan is often cited by papers focused on DNA Repair Mechanisms (10 papers), Glioma Diagnosis and Treatment (5 papers) and Epigenetics and DNA Methylation (5 papers). William Burgan collaborates with scholars based in United States, India and Australia. William Burgan's co-authors include Kevin Camphausen, Philip J. Tofilon, Michael Cerra, Kelli Oswald, David Cerna, Hideaki Dote, Jeffery S. Russell, Katie Beam, Donna Carter and Melinda G. Hollingshead and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Clinical Cancer Research.

In The Last Decade

William Burgan

27 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William Burgan United States 22 1.4k 575 309 298 259 27 1.9k
Yasir H. Ibrahim United States 12 1.1k 0.8× 828 1.4× 305 1.0× 145 0.5× 249 1.0× 22 1.6k
Teresa Klinowska United Kingdom 22 1.3k 0.9× 717 1.2× 419 1.4× 116 0.4× 252 1.0× 62 2.0k
Josef Brueggen Switzerland 10 1.8k 1.3× 633 1.1× 348 1.1× 230 0.8× 381 1.5× 14 2.4k
Lily L. Remsing Rix United States 19 902 0.6× 429 0.7× 179 0.6× 358 1.2× 115 0.4× 28 1.8k
Neil A. O’Brien United States 23 821 0.6× 1.0k 1.8× 455 1.5× 191 0.6× 265 1.0× 55 1.6k
M. Joan Allalunis‐Turner Canada 21 822 0.6× 444 0.8× 205 0.7× 160 0.5× 416 1.6× 33 1.3k
Janis Liebetanz Switzerland 10 976 0.7× 392 0.7× 112 0.4× 270 0.9× 177 0.7× 11 1.6k
María G. Kuba United States 14 897 0.6× 773 1.3× 445 1.4× 184 0.6× 370 1.4× 20 1.5k
Nandini Dey United States 25 1.4k 1.0× 907 1.6× 365 1.2× 146 0.5× 432 1.7× 71 2.1k
István Peták Hungary 24 1.1k 0.8× 647 1.1× 262 0.8× 176 0.6× 318 1.2× 61 1.8k

Countries citing papers authored by William Burgan

Since Specialization
Citations

This map shows the geographic impact of William Burgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Burgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Burgan more than expected).

Fields of papers citing papers by William Burgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Burgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Burgan. The network helps show where William Burgan may publish in the future.

Co-authorship network of co-authors of William Burgan

This figure shows the co-authorship network connecting the top 25 collaborators of William Burgan. A scholar is included among the top collaborators of William Burgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Burgan. William Burgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cornilescu, Gabriel, Lakshman Bindu, Fa-An Chao, et al.. (2024). Natural Product Graveoline Modulates Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Membrane Association: Insights from Advanced Spectroscopic Studies. ACS Pharmacology & Translational Science. 7(7). 1983–1995. 2 indexed citations
2.
Lai, Lo, Nicole Fer, William Burgan, et al.. (2022). Classical RAS proteins are not essential for paradoxical ERK activation induced by RAF inhibitors. Proceedings of the National Academy of Sciences. 119(5). 18 indexed citations
3.
Mukhopadhyay, Suman, Debanjan Goswami, Pavan P. Adiseshaiah, et al.. (2020). Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers. Cancer Research. 80(8). 1630–1643. 193 indexed citations
4.
Goswami, Debanjan, De Chen, Yue Yang, et al.. (2020). Membrane interactions of the globular domain and the hypervariable region of KRAS4b define its unique diffusion behavior. eLife. 9. 21 indexed citations
5.
Gillet, Jean-Pierre, Jesper B. Andersen, James P. Madigan, et al.. (2015). A Gene Expression Signature Associated with Overall Survival in Patients with Hepatocellular Carcinoma Suggests a New Treatment Strategy. Molecular Pharmacology. 89(2). 263–272. 21 indexed citations
6.
Shankavaram, Uma, Markus Bredel, William Burgan, et al.. (2011). Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma. Journal of Cellular and Molecular Medicine. 16(3). 545–554. 20 indexed citations
7.
Buchanan, Ian M., Tamalee Scott, Anita Tandle, et al.. (2010). Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102. Journal of Cellular and Molecular Medicine. 15(9). 1999–2006. 33 indexed citations
8.
Chung, Eun Joo, Aaron Brown, Hiroaki Asano, et al.. (2009). In vitro and In vivo Radiosensitization with AZD6244 (ARRY-142886), an Inhibitor of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase 1/2 Kinase. Clinical Cancer Research. 15(9). 3050–3057. 75 indexed citations
9.
Russo, Andrea, Hyuk‐Chan Kwon, William Burgan, et al.. (2009). In vitro and In vivo Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016. Clinical Cancer Research. 15(2). 607–612. 132 indexed citations
10.
Russo, Andrea, William Burgan, Donna Carter, et al.. (2009). Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts. Molecular Cancer Therapeutics. 8(6). 1589–1595. 71 indexed citations
11.
Chinnaiyan, Prakash, David Cerna, William Burgan, et al.. (2008). Postradiation Sensitization of the Histone Deacetylase Inhibitor Valproic Acid. Clinical Cancer Research. 14(17). 5410–5415. 87 indexed citations
12.
Kil, Whoon Jong, David Cerna, William Burgan, et al.. (2008). In vitro and In vivo Radiosensitization Induced by the DNA Methylating Agent Temozolomide. Clinical Cancer Research. 14(3). 931–938. 95 indexed citations
13.
Russo, Andrea, Deborah E. Citrin, William Burgan, et al.. (2008). In Vitro and In vivo Radiosensitization of Glioblastoma Multiforme by Poly (ADP-ribose) Polymerase Inhibitor, GPI 21016. International Journal of Radiation Oncology*Biology*Physics. 72(1). S714–S714. 1 indexed citations
14.
Dote, Hideaki, William Burgan, Kevin Camphausen, & Philip J. Tofilon. (2006). Inhibition of Hsp90 Compromises the DNA Damage Response to Radiation. Cancer Research. 66(18). 9211–9220. 130 indexed citations
15.
Peña, Lorena de la, William Burgan, Melinda G. Hollingshead, et al.. (2006). Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells. Molecular Cancer Therapeutics. 5(6). 1504–1510. 40 indexed citations
16.
Dote, Hideaki, David Cerna, William Burgan, et al.. (2005). Enhancement of In vitro and In vivo Tumor Cell Radiosensitivity by the DNA Methylation Inhibitor Zebularine. Clinical Cancer Research. 11(12). 4571–4579. 80 indexed citations
17.
Barker, Christopher A., et al.. (2005). 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (Triapine): A Ribonucleotide Reductase Inhibitor with Potent Radiosensitizing Properties. International Journal of Radiation Oncology*Biology*Physics. 63. S170–S170. 2 indexed citations
18.
Camphausen, Kevin, David Cerna, Tamalee Scott, et al.. (2004). Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid. International Journal of Cancer. 114(3). 380–386. 169 indexed citations
19.
Camphausen, Kevin, et al.. (2004). Flavopiridol enhances human tumor cell radiosensitivity and prolongs expression of γH2AX foci. Molecular Cancer Therapeutics. 3(4). 409–416. 27 indexed citations
20.
Russell, Jeffery S., William Burgan, Kelli Oswald, Kevin Camphausen, & Philip J. Tofilon. (2003). Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allylamino-17- demethoxygeldanamycin: a multitarget approach to radiosensitization.. PubMed. 9(10 Pt 1). 3749–55. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasir H. Ibrahim Breakdown of academic impact, for papers by Teresa Klinowska Breakdown of academic impact, for papers by Josef Brueggen Breakdown of academic impact, for papers by Lily L. Remsing Rix Breakdown of academic impact, for papers by Neil A. O’Brien Breakdown of academic impact, for papers by M. Joan Allalunis‐Turner Breakdown of academic impact, for papers by Janis Liebetanz Breakdown of academic impact, for papers by María G. Kuba Breakdown of academic impact, for papers by Nandini Dey Breakdown of academic impact, for papers by István Peták
Rankless by CCL
2026